Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Dizziness · people with drug‐resistant focal epilepsy

1 finding from 1 review

Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
1.64 [0.85, 3.16]
3 studies · 1286 participants
Low

Dizziness · people with drug‐resistant focal epilepsy

Pregabalin may leads to higher adverse effect: dizziness compared with placebo (low certainty).

1 finding from 1 review

Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
RR 3.15 [2.23, 4.44]
7 studies · 2193 participants
Low